Cancer News and Research

Latest Cancer News and Research

Scripps Research Institute enters agreement with Aileron Therapeutics

The Scripps Research Institute and Aileron Therapeutics today announced that they have entered into an agreement that will add Scripps Research's "Click" chemistry to Aileron's proprietary stabilized peptide and protein technology platforms, which includes the Stapled Peptide technology.

1 Dec 2010

HOANNJ announces collaboration to enhance cancer care through United Network of US Oncology

Hematology Oncology Associates of Northern New Jersey, P.A. (HOANNJ), an independent physician-owned, single-specialty oncology practice with offices in Morristown and Parsippany, and US Oncology, Inc., the nation's leading integrated oncology company, today announced their new collaboration to protect, expand and enhance patient access to high-quality, evidence-based cancer care and clinical research through the United Network of US Oncology.

1 Dec 2010

Physician-scientists enroll patients with NSCLC cancer in MAGE-A3 Phase III trial

An experimental immunotherapy may someday become the newest weapon against lung cancer. Physician-scientists from Weill Cornell Medical College and Columbia University Medical Center are enrolling patients with non-small cell lung cancer (NSCLC) at NewYork-Presbyterian Hospital as part of an ongoing Phase III trial.

1 Dec 2010

Experts suggest measure to raise awareness about skin cancer among retired population

Failure to get moles and skin changes checked out by a doctor has contributed to a steep rise in deaths from malignant melanoma among pensioners, experts warned today (Tuesday).

1 Dec 2010

China Medical Technologies prices $125 million convertible senior notes offering

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it increased the size of its previously announced offering of convertible senior notes. On November 30, 2010, the Company priced US$125 million in aggregate principal amount of convertible senior notes due 2016 at an issue price of 100%. The transaction is expected to close on December 6, 2010, subject to satisfaction of various customary closing conditions.

1 Dec 2010

Results of pixantrone phase III trial for non-Hodgkin's lymphoma to be presented at Hematology Meeting

Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.

1 Dec 2010

New cerebrospinal fluid biomarkers to monitor Parkinson's disease

KineMed Inc. presents data on the new use of cerebrospinal fluid biomarkers of microtubule-mediated neuronal transport for the monitoring of disease progression and the advancement of therapeutic interventions in Parkinson's disease, a debilitating neurological condition with considerable unmet need for new treatments.

1 Dec 2010

Precision Therapeutics to present abstracts on breast cancer therapy at San Antonio Symposium

Precision Therapeutics will present two abstracts at the 33rd Annual San Antonio Breast Cancer Symposium, which will be held December 8-12, 2010 in San Antonio, Texas.

1 Dec 2010

Research could lead to new drug treatment for metabolic diseases

A team of Harvard School of Public Health (HSPH) scientists report finding a molecular "switch" that can "turn off" some cellular processes that are protective against aging and metabolic diseases. While more research is needed, the findings may open doors for new drug treatments to halt or slow development of metabolic diseases like type 2 diabetes or heart disease. The research findings appear in the December 1, 2010 issue of Cell Metabolism.

1 Dec 2010

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke.

1 Dec 2010

USC purchases WaferGen SmartChip system for Molecular Pathways and Drug Discovery center

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that the University of Southern California (USC) has purchased the WaferGen SmartChip system for its USC Center for Molecular Pathways and Drug Discovery to discover and validate biomarkers for pancreatic and colorectal cancer applications to expedite the development of a cancer therapy. USC purchased a solution that includes the SmartChip platform and validated gene panels for biomarker profiling.

1 Dec 2010

Men with long index fingers at lower risk of prostate cancer

Men who have long index fingers are at lower risk of prostate cancer, a new study published today in the British Journal of Cancer has found.

1 Dec 2010

Study shows link between reduced hormone therapy and decline in breast cancer

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer. The researchers saw such a striking decrease, they believe they also have uncovered indirect evidence that hormones promote breast tumor growth.

1 Dec 2010

Los Angeles prosthodontist provides effective dental treatment for oral cancer patients

Oral cancer is a common condition affecting over 30,000 Americans each year. Worldwide the number falls into the hundreds of thousands, and a significant percentage of those with oral cancer end up losing teeth and normal mouth function in the absence of early cancer detection and treatment.

1 Dec 2010

Study indicates risk of developing radiation-induced cancer from CT may be lower than previously thought

The risk of developing radiation-induced cancer from computed tomography (CT) may be lower than previously thought, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2010

Annual mammography screening reduces risk of mastectomy

Having a yearly mammogram greatly reduces the risk of mastectomy following breast cancer in women between the ages of 40 and 50, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2010

Migraine headache with aura increases risk of stroke among women: Research

Women with a history of migraine headache with aura (transient neurological symptoms, mostly visual impairments) are at increased risk of stroke. However, according to new research reported in Circulation: Journal of the American Heart Association stroke events in women with migraine with aura are more likely to have mild or no disability compared to those without migraine.

1 Dec 2010

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.

1 Dec 2010

Roche NimbleGen announces NewGene as first certified service provider in the UK

Roche NimbleGen announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company.

1 Dec 2010

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.

1 Dec 2010

Cancer News and Research

Latest Cancer News and Research

Scripps Research Institute enters agreement with Aileron Therapeutics

HOANNJ announces collaboration to enhance cancer care through United Network of US Oncology

Physician-scientists enroll patients with NSCLC cancer in MAGE-A3 Phase III trial

Experts suggest measure to raise awareness about skin cancer among retired population

China Medical Technologies prices $125 million convertible senior notes offering

Results of pixantrone phase III trial for non-Hodgkin's lymphoma to be presented at Hematology Meeting

New cerebrospinal fluid biomarkers to monitor Parkinson's disease

Precision Therapeutics to present abstracts on breast cancer therapy at San Antonio Symposium

Research could lead to new drug treatment for metabolic diseases

Vitamin D supplementation may reduce risk of diabetes, heart disease: Research

USC purchases WaferGen SmartChip system for Molecular Pathways and Drug Discovery center

Men with long index fingers at lower risk of prostate cancer

Study shows link between reduced hormone therapy and decline in breast cancer

Los Angeles prosthodontist provides effective dental treatment for oral cancer patients

Study indicates risk of developing radiation-induced cancer from CT may be lower than previously thought

Annual mammography screening reduces risk of mastectomy

Migraine headache with aura increases risk of stroke among women: Research

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

Roche NimbleGen announces NewGene as first certified service provider in the UK

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in